Table 2.
Adherent Use | Non-Adherent Use | Non-Use | |
---|---|---|---|
Patient-years (% of Total Follow-up) | 11,192 (35.0%) | 3,497 (10.9%) | 17,268 (54.0%) |
No. Ischemic Stroke Events | 163 | 67 | 471 |
Incidence Ischemic Stroke per 100 p-y (CI) | 1.46 (1.25-1.70) | 1.92 (1.51-2.43) | 2.73 (2.49-2.99) |
Abbreviation: P-y=person-years.
Every day of the study, adherent use was defined as having at least 80% of the previous 30 days covered with oral anticoagulation. Non-adherent use was defined as having more than 0% but less than 80% of the previous 30 days covered with oral anticoagulation. Non-use was defined as having 0% of the previous 30 days covered with oral anticoagulation.
The proportion of follow-up indicates the proportion of the total follow-up for all study participants that was spent on each time-dependent treatment group.